The Outlook for Multiple Sclerosis: Targeted Therapy for Optimal Patient Outcomes

Reserve your spot today for the Satellite Dinner Symposium
The Outlook for Multiple Sclerosis: Targeted Therapy for Optimal Patient Outcomes

Jointly provided by
Impact Education, LLC    
This activity is supported by an independent educational grant from Genzyme Corporation.

Wednesday, October 5, 2016
6:00 PM - 8:00 PM
Gaylord National Hotel & Convention Center
Room: Woodrow Wilson BC
National Harbor, MD
Held in conjunction with

AMCP Nexus 2016

Click here to download the slides from this symposium.

  • Evidence-based treatment for MS - from screening to treatment
  • Linking patient types to appropriate MS treatments
  • Benefit design strategies to enhance patient outcomes
James Kenney, Jr., RPh, MBA
Manager, Specialty and Pharmacy Contracts
Harvard Pilgrim Health Care
Scott Newsome, DO, MSCS
Director, Neurology Outpatient Services
Director, Neurology Infusion Center
Division of Neuroimmunology and Neuroinfectious Diseases
Johns Hopkins School of Medicine
Edmund Pezalla, MD, MPH
National Medical Director, Pharmacy Policy and Strategy

This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, members of AMCP, and other managed health care professionals attending AMCP Nexus 2016.


Multiple sclerosis (MS) is a complex disease that requires a collaborative approach to care to achieve optimal patient care and outcomes. Disease-modifying therapies (DMTs) are a core component of MS management. Given current constraints on health care expenditures, the relative cost-effectiveness of these therapies needs to be considered when making treatment decisions. Due to a lack of head to head trials it is difficult to determine which therapy would be most effective for MS; however, it is possible to evaluate current therapies based on their effects on sustained disability, relapse rate, lesion load, brain atrophy, and cognitive dysfunction. Members of the clinical team, as well as patients, need to coordinate these efforts when choosing the appropriate therapy and continually monitor the disease, manage symptoms and the psychological aspects of the disease, and engage the patient through coordinated patient education in order to achieve optimal clinical, economic, and humanistic outcomes. Therefore, it is important for managed care professionals to be aware of and engaged in the care and treatment of MS patients. This symposium will provide an update on available treatments, best practices in care coordination among multiple stakeholders, and benefit design considerations to optimize patient outcomes.


At the conclusion of this activity, participants should be able to demonstrate improved ability to:
  • Use current and emerging clinical data to enhance therapeutic decision-making and optimize outcomes for MS treatments
  • Implement the necessary collaborations, processes, and systems that will improve access to MS screening and drive successful MS treatment in a complicated new accountable care ecosystem
  • Evaluate current treatment guidelines to select the optimal treatment for specific patient types
  • Provide accurate and appropriate counsel as part of the managed care treatment team

Date and Time
Wednesday, October 5, 2016
6:00 PM - 8:00 PM
Gaylord National Hotel & Convention Center
Room: Woodrow Wilson BC
National Harbor, MD

6:00 PM Dinner and Registration
6:05 PM Pre-Activity Learning Assessment and Opening Comments
6:10 PM Evidence-Based Treatment for MS - Screening to Treatment
Scott Newsome, DO, MSCS
6:50 PM Linking Patient Types to Appropriate MS Treatments
Edmund Pezalla, MD, MPH
7:15 PM Benefit Design Strategies to Enhance Patient Outcomes
James Kenney, Jr., RPh, MBA
7:40 PM Question and Answer Session
7:55 PM Key Takeaways and Closing Comments
Post-Activity Assessment and Evaluation
8:00 PM Adjournment
Physician Continuing Medical Education
Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Impact Education, LLC. Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Continuing Education
Accreditation Statement
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation
Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hours (0.20 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - 0809-9999-16-414-L01-P

Type of Activity: Application

For Pharmacists: Upon receipt of a completed activity evaluation form, you will receive an email from Postgraduate Institute for Medicine within 3 weeks with a link and directions to submit your credit to the NABP CPE Monitor Service.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.

Fee Information
Please note: No additional fee is required to attend this CPE/CME activity; however, registration to AMCP Nexus 2016 is required.

Pre-registration will close at 12:00 pm on October 4, 2016.
Walk-in registration will be available at the time of the program.
If you have any questions, please call (215) 619-8812 or email

Register Now